ProQR Therapeutics (PRQR) Net Margin Growth (3y) (2015 - 2026)
ProQR Therapeutics (PRQR) Net Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | 73,896.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73,896.00 |
| Dec 31, 2025 | 167,948.00 |
| Sep 30, 2025 | 248,193.00 |
| Jun 30, 2025 | 113,618.00 |
| Mar 31, 2025 | 102,555.00 |
| Dec 31, 2024 | 741,015.00 |
| Sep 30, 2024 | 150,478.00 |
| Jun 30, 2024 | 649,516.00 |
| Mar 31, 2024 | -6,793.00 |
| Dec 31, 2023 | -3,525.00 |
| Sep 30, 2023 | -31,754.00 |
| Jun 30, 2023 | -53,688.00 |
| Mar 31, 2023 | -129,983.00 |
| Dec 31, 2022 | -174,044.00 |
| Sep 30, 2022 | -277,435.00 |
| Jun 30, 2022 | -137,468.00 |
| Mar 31, 2022 | -115,253.00 |
| Dec 31, 2021 | -752,311.00 |
| Sep 30, 2021 | -162,488.00 |
| Jun 30, 2021 | -644,211.00 |